TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
AUTL

Autolus Therapeutics plc

Healthcare · Biotechnology

1.90$ +4.3% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow AUTL
Line item 2015 2016 2017 2018 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – – –
– -86.9% +111.1% +9.5% +0.0% +317.3% +22.7% +49.5% -12.2% -11.5% +17.5% +27.2%
– – +39.7% +59.4% +0.0% +501.0% -33.4% -50.6% +20.9% -6.7% +38.1% -6.7%
– – -8.8% +114.8% +43.2% +250.1% -49.1% -32.6% +116.0% – – –
– – – – +0.0% -398.9% – +193.5% -4.1% -92.6% -8,201.0% –
– +143.4% +55.0% +205.0% +0.0% +112.8% -21.4% -39.7% +22.4% +1.3% +216.9% -22.1%
– +146.0% +55.0% +231.4% -19.8% +144.2% -21.4% -39.7% +22.4% +1.3% +3,491.4% –
– +1,064,049,900.0% -74.8% +387.0% -102.0% – – – – – – –
– +163.5% +296.3% -8.0% +0.0% -7.3% -31.6% +281.7% -21.3% -100.4% – -100.7%
– +119.2% +510.5% -20.2% +0.0% -107.0% – – -54.0% -297.6% – –
– – – – – – – – – – – –

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?